HealthTech Consulting vs Growth Partner: What's the Difference?
Healthtech consulting bills for slides. A growth partner stays until deals close. Here's how the two models differ — and when you actually need each.
The consulting model
Traditional healthtech consulting sells deliverables: market sizing, segmentation, GTM strategy, org design. You pay for the slides. What you do with them is on you.
This works when you already have a strong commercial team that needs an outside perspective on a specific decision.
The growth partner model
A growth partner embeds with the commercial team and stays accountable to the outcome — pipeline, KOL trust, deals closed — not to the deck.
Compensation is often partially performance-based. The work continues until the metric moves, not until the engagement letter expires.
When to use which
Use a consulting firm when the question is strategic and bounded ('Should we enter Germany next?').
Use a growth partner when the question is execution-shaped ('We need to build trust with cardiology KOLs and convert it into health-system contracts in 12 months').
How we work
Futurize NOW is a growth partner, not a consulting firm. The Trust API framework is how we operationalize trust into commercial outcomes — and we share risk by tying part of our fee to the result.
Ready to put this into practice?
We embed with HealthTech, pharma, and medical device commercial teams as growth partners — not consultants. Start with a 10-minute Trust Audit or book a discovery call.